Literature DB >> 921252

Gentamicin and tobramycin penetration into synovial fluid.

T H Dee, F Kozin.   

Abstract

The penetration of gentamicin and tobramycin into the synovial fluid of 12 patients with nontraumatic joint effusions was studied. Simultaneous serum and synovial fluid specimens taken after the intramuscular or intravenous administration of an antimicrobial agent were assayed. Synovial fluid levels of antibiotic were >50% of serum levels in all subjects studied. In five patients, synovial fluid levels were equal to or exceeded simultaneous serum values. These results suggest that intra-articular injection of aminoglycoside antibiotics is not necessary in the treatment of infectious arthritis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921252      PMCID: PMC429965          DOI: 10.1128/AAC.12.4.548

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Transport of gentamicin into synovial fluid.

Authors:  D C Marsh; E B Matthew; R H Persellin
Journal:  JAMA       Date:  1974-04-29       Impact factor: 56.272

2.  Ampicillin and kanamycin concentrations in joint fluid.

Authors:  E A Baciocco; R L Iles
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

3.  Gentamicin and carbenicillin penetration into the septic joint.

Authors:  A Chow; R Hecht; R Winters
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

4.  Antibiotic concentrations in septic joint effusions.

Authors:  J D Nelson
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

5.  Antibacterial activity of synovial fluid during therapy of septic arthritis.

Authors:  R H Parker; F R Schmid
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

6.  Comparative clinical study of tobramycin and gentamicin.

Authors:  J Klastersky; C Hensgens; A Henri; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

  6 in total
  6 in total

1.  Aminoglycoside therapy: current and prospective uses.

Authors:  J E Leggett
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Pharmacokinetic optimisation of the treatment of septic arthritis.

Authors:  K A Hamed; J Y Tam; C G Prober
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

3.  Aztreonam penetration into synovial fluid and bone.

Authors:  C M MacLeod; E A Bartley; J O Galante; L T Friedhoff; R Dhruv
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Curative effects of tobramycin or gentamicin therapy on mouse arthritis caused by Mycoplasma pulmonis.

Authors:  R A Dixon
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

Review 5.  Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.

Authors:  Tetsuya Matsumoto
Journal:  Clin Pharmacol       Date:  2014-09-26

6.  Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An in Vivo Study With an Experimental Model of Foreign-Body Infection.

Authors:  Corinne Ruppen; Thomas Mercier; Denis Grandgirard; Stephen L Leib; Cristina El Haj; Oscar Murillo; Laurent Decosterd; Parham Sendi
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.